The Search Is Over: JPMorgan, Amazon and Berkshire Hathaway Find CEO to Head Up Health Care Firm

Photo of Chris Lange
By Chris Lange Updated Published
The Search Is Over: JPMorgan, Amazon and Berkshire Hathaway Find CEO to Head Up Health Care Firm

© Thinkstock

Amazon.com Inc. (NYSE: AMZN), JPMorgan Chase & Co. (NYSE: JPM) and Berkshire Hathaway Inc. (NYSE: BRK-B) are now making their combined health care plan a reality with the appointment of a new chief executive officer. The trio originally set out to subvert the current health insurance system and create a company of their own that could better handle the needs of their employees, and it seems that this plan is now coming to fruition.

According to a press release, Ariadne Labs founder and Executive Director Dr. Atul Gawande has been named the CEO of the new Amazon, JPMorgan, Berkshire Hathaway nonprofit health care organization. The appointment was announced Wednesday jointly by Amazon CEO Jeff Bezos, Berkshire Hathaway CEO Warren Buffett and JPMorgan CEO Jamie Dimon.

Gawande will assume this role effective July 9, and the new company will be headquartered in Boston and will operate as an independent entity that is free from profit-making incentives and constraints.

[nativounit]

Gawande is a globally-renowned surgeon, writer and public health innovator. He practices general and endocrine surgery at Brigham and Women’s Hospital and is a professor at the Harvard T.H. Chan School of Public Health and Harvard Medical School. He is founding executive director of the health systems innovation center, Ariadne Labs.

Gawande commented:

I am thrilled about this opportunity as it aligns perfectly with my personal mission. I have devoted my public health career to working with colleagues to build scalable solutions for better health care delivery in the U.S. and across the world. Now, I have the support of these remarkable organizations to pursue this mission for their employees and families in ways that incubate better models of care for all. And I will be able to do so while maintaining my own voice and continuing to enable Ariadne Labs’ powerful and complementary work.

[recirclink id=471676]

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

SMCI Vol: 128,836,317
ON Vol: 12,044,310
GLW Vol: 18,574,393
MU Vol: 53,140,821
ABBV Vol: 9,912,803

Top Losing Stocks

CTRA Vol: 73,319,495
MRNA Vol: 8,363,487
PLTR Vol: 56,918,231
VRSN Vol: 1,691,263
CMG Vol: 18,457,730